Pune, India, March 27, 2025 /press release/- Market Research Future Published a Half Cooked Research Report on Global Healthcare OEM Research Report.
Market Highlights
OEM healthcare provides products and solutions for healthcare management which includes medical devices and equipments and software solutions. Demand for surgical and diagnostic medical devices is increasing with an increase in burden of diseases, need of early diagnoses, patient health and safety. Also, electronic health records and healthcare management softwares drive this market.
The Healthcare OEM Market is anticipated to reach USD 0.33 billion by 2032 at 9.80% CAGR during the forecast period 2023 -2032
Taste the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Healthcare OEM market Research Report –Global Forecast to 2032.”
Global Healthcare OEM Market Players:
Key players in Healthcare OEM market are: Johnson & Johnson (U.S), Siemens Healthcare GmbH (Germany), GE Healthcare (U.K.), Baxter International (U.S) Koninklijke Philips N.V. (Netherlands), Aramark (U.S.), Toshiba Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Hitachi Medical Systems America, Inc. (U.S.), Esaote SpA (Italy), and Drägerwerk AG & Co. KGaA (Germany), Accenture Plc. (U.S.), Cognizant Technology Solutions Corporation (U.S.), Infosys Ltd. (India), Allscripts Healthcare Solutions (U.S), Dell (U.S), IBM Corporation (U.S), Wipro (U.S), Tata Consultancy Services Ltd. (India), Xerox Corporation (U.S.)
Global Healthcare OEM market has been segmented on the basis of types of OEM products which includes healthcare software and medical device and instruments. Healthcare softwares include HR, Billing and Claims Management, Front/Back-Office Operations, Provider Management, OT Management, Financial Management and other softwares. Medical devices and instruments includes surgical and diagnostic devices and instruments. Surgical devices and instruments are artery forceps, retractors, saws and plaster instruments, scalpers and operating knives, scissors, stents, tracheotomy instruments, eye instruments, suture instruments, needles and other devices are nasal instruments, sterilization instruments, gall bladder instruments, kidney instruments and probes and directors. Diagnostic instruments are ultrasound, X-ray, MRI, PET scan, SPECT scan. On the basis of OEM solutions the market is segmented into quality control and regulatory compliance, manufacturing and fabrication, packaging and sterilization, product design and development, order fulfillment & flexible distribution, technical support and project management and on the basis of application which includes healthcare administration, dentistry, surgery, laboratory, veterinary, pharmaceutical and cosmetics, ophthalmology, dialysis and other applications.
Regional Analysis
Globally, America accounts for the highest number of healthcare OEMs. The Americas consist of two regions namely North America and South America. Emergence and increasing adoption of information technology for healthcare management and concentration of major medical devices & software companies in the U.S drive this market in North America. Increasing awareness regarding electronic health records and huge demand for health IT also boost the growth of this market. Johnson & Johnson, Baxter International, Hitachi Medical Systems America, Inc., Accenture Plc., Cognizant Technology Solutions Corporation, Allscripts Healthcare Solutions, Dell are among the world’s largest multinational healthcare companies. These companies provide healthcare solutions with highly innovative technology for all the specialties in medicine. Factors driving the growth of OEM market in South America are focus for healthcare providers towards managed care, patient safety and continuous quality improvement. New entrants have to face barriers like competition amongst present market players, large number of products available and lack financial resources required for research and development activities.